Novel Therapies for Type 2 Diabetes

Highlighting new drug classes, such as SGLT-2 inhibitors and GLP-1 receptor agonists, and their impact on glucose control and cardiovascular outcomes. Several novel therapies have emerged in recent years for the treatment of type 2 diabetes. These therapies offer alternative mechanisms of action, improved efficacy, and reduced side effects compared to traditional treatment options.


  • Glucose-Lowering Medications
  • Personalized Medicine Approaches
  • Bariatric Surgery and Metabolic Interventions
  • Gut Microbiota and Probiotics
  • Regenerative Medicine and Stem Cell Therapies

Related Conference of Novel Therapies for Type 2 Diabetes

May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

5th World Congress on Endocrine and Diabetes

Rome, Italy
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Novel Therapies for Type 2 Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in